Expression of inducible nitric oxide synthase in trophoblasts and deciduas in early medical abortion

Abstract

The purpose of this study was to investigate the expression of inducible nitric oxide synthase in trophoblasts and deciduas in early medical abortion, and study the relationship of medical abortion through mifepristone and inducible nitric oxide synthase (iNOS) in early pregnancy. Expression of iNOS in trophoblasts and deciduas was detected by both in situ hybridization and immunohistochemical assay in 40 patients (experimental group); the positive expression of iNOS was represented by number density (N/S) and positive unit (Pu) using computer color magic image analysis system (CMIAS). All results were compared with that obtained from vacuum aspiration. In the experimental group, N/S and Pu in trophoblasts were 0.120 ± 0.010 and 15.3 ± 2.6, respectively, while in the control group, they were 0.021 ± 0.003 and 3.1 ± 0.5, respectively, and there were significant differences between the two groups. By immunohistochemical assay, N/S and Pu were 0.090 ± 0.010, 10.24 ± 1.55 vs 0.016 ± 0.002, 1.26 ± 0.33 in the trophoblasts of the two groups; there were also significant differences between the two groups. There were lower iNOS expressions in deciduas by in situ hybridization and immunohistochemical assay, and the difference between the two groups was not significant.It was concluded that mifepristone induced medical abortion through the expression of iNOS in trophoblasts but not in deciduas.

Key words： mifepristone; inducible nitric oxide synthase; early pregnancy; placental immunity

References

1 SrivastavaM D, ThomasA, SrivastavaB I, CheckJ H. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma, 2007, 48(8): 1610-1617

2 KleiverdaG. First trimester medical abortion: a good method that is seldom used in The Netherlands. Ned Tijdschr Geneeskd, 2006, 150(14): 766-769

3 XiaG Q, SunY Y. Expression of apoptosis and inducible nitric oxide synthase in chorion in early pregnancy. Reprod Contracept, 2001, 12(1): 56-60

4 HausknechtR. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception, 2003, 67(6): 463-465

5 De GrandiP, GiudiciG. Oral administration of an antiprogesterone (Mifepristone, RU 468) for preparing the cervix uteri for pregnancy interruption during the first trimester. J Gynecol Obstet Biol Reprod, 1989, 18(6): 801-808

6 XiaG Q, XiongY L, SunY Y. Effect of mifepristone on the telomerase activity in chorion and decidua during early gestation. Reprod Contracept, 2004, 15(4): 245-248

7 LidegaardO, LarsenJ F, BlaabjergJ, LarsenE. The first 100 early medical abortions. Ugeskr Laeger, 1999, 161(22): 3278-3281

8 VervestH A, HaspelsA A. Initial Dutch experiences with early pregnancy interruption using the antiprogesterone agent mifepriston. Ned Tijdschr Geneeskd, 1985, 129(35): 1680-1683

9 PappC, SchatzF, KrikunG, HausknechtV, LockwoodC J. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium. Early Pregnancy, 2000, 4(4): 230-239

10 ParadisiR, FabbriR, BattagliaC, FacchinettiF, VenturoliS. Nitric oxide levels in women with missed and threatened abortion: results of a pilot study. Fertil Steril, 2007, 88(3): 744-748

11 MarinoniE, Di IorioR, LucchiniC, Di NettaT, LetiziaC, CosmiE V. Adrenomedullin and nitric oxide synthase at the maternal-decidual interface in early spontaneous abortion. J Reprod Med, 2004, 49(3): 153-161

12 HämäläinenM, LiljaR, KankaanrantaH, MoilanenE. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors. Pulm Pharmacol Ther, 2008, 21(2): 331-339

13 UrbanG, MarinoniE, Di IorioR, LucchiniC, AloP, Di TondoU. New placental factors: Between implantation and inflammatory reaction. Early Pregnancy, 2001, 5(1): 70-71

14 EisA L, BrockmanD E, MyattL, Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am J Reprod Immunol, 1997, 38(4): 289-294

15 ZenclussenA C, SollwedelA, BertojaA Z, GerlofK, ZenclussenM L, WoiciechowskyC, VolkH D. Heme oxygenase as a therapeutic target in immunological pregnancy complications. Int Immunopharmacol, 2005, 5(1): 41-51

16 OgandoD G, PazD, CellaM, FranchiA M. The fundamental role of increased production of nitric oxide in lipopolysaccharide-induced embryonicresorption in mice. Reproduction, 2003, 125(1): 95-110

17 MatsumuraM, KakishitaH, SuzukiM, BanbaN, HattoriY. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci, 2001, 69(9): 1067-1077

18 ZhangD, KishiharaK, WangB, MizobeK, KuboC, NomotoK. Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes. J Neuroimmunol, 1998, 92(1,2): 139-151

19 MillerL, AlleyE W, MurphyW J, RussellS W, HuntJ S. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol, 1996, 59(3): 442-450

20 GoldeS, ColesA, LindquistJ A, CompstonA. Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro. Eur J Neurosci, 2003, 18(9): 2527-2537

21 XiaG, SunY. Expression of the inducible nitric oxide synthase isoform in chorionic villi in the early spontaneous abortion. J Tongji Med Univ, 2000, 20(4): 338-339

22 HaddadE K, DuclosA J, BainesM G. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med, 1995, 182(4): 1143-1151

23 MiechR P, Pathopharmacology of excessive hemorrhage in mifepristone abortions. Ann Pharmacother, 2007, 41(12): 2002-2007

24 Väisänen-TommiskaM, ButzowR, YlikorkalaO, MikkolaT S. Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy. Hum Reprod, 2006, 21(8): 2180-2184

25 De GrandiP, GiudiciG. Oral administration of an antiprogesterone (Mifepristone, RU 486) for preparing the cervix uteri for pregnancy interruption during the first trimester. J Gynecol Obstet Biol Reprod, 1989, 18(6): 801-808